Barry Buckland has been the CEO of BiologicB LLC since 2009 and serves as a Technical Advisor at Hilleman Laboratories.
He served as Head of BioProcess Development at the Protein Sciences Corporation. His career in the Pharma industry includes his leadership of Merck’s bioprocess R&D Group. He is an experienced expert for the Development of Biologics with a special focus on vaccines and therapeutic proteins. Dr. Buckland was elected as Fellow in the UCL in 1998 and member of US National Academy of Engineering in 1997.